NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
15.02
+0.30 (2.04%)
At close: Feb 26, 2026, 4:00 PM EST
15.06
+0.04 (0.27%)
Pre-market: Feb 27, 2026, 4:00 AM EST
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $500.28 million as of February 27, 2026. Its market cap has increased by 36.27% in one year.
Market Cap
500.28M
Enterprise Value
511.45M
1-Year Change
36.27%
Ranking
Category
Stock Price
$15.02
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $500.28M, an increase of 27.21%. That is a compound annual growth rate of 5.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 500.28M | -2.72% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Bionics | 577.86M |
| Perspective Therapeutics | 576.41M |
| Varex Imaging | 566.75M |
| Cytek Biosciences | 562.61M |
| Pacific Biosciences of California | 537.40M |
| Orthofix Medical | 528.70M |
| Cerus | 499.43M |
| BrainsWay | 465.90M |